Precision Nutrition Strategies for Improving the Quality of Life of Pre-senior and Senior Populations
Strategies for Improving the Quality of Life of Pre-senior and Senior Populations Based on Precision Nutrition (Proyecto Nutriprecisión)
1 other identifier
interventional
126
1 country
1
Brief Summary
The number and proportion of people aged 60 years old and over is increasing worldwide. Ageing is characterized by a progressive loss of physiological integrity, leading to impaired function and increased vulnerability to death. This deterioration is the primary risk factor for major chronic diseases including diabetes, cardiovascular disease, and neurodegenerative disorders. The incidence of chronic conditions frequently rises sharply with age, after long exposure to unhealthful lifestyles involving the consumption of unhealthy diets and physical inactivity. Consequently, integrated dietary strategies and actions are required to promote healthy ageing and target major causes of morbidity and mortality in senior populations. The promising field of precision nutrition is rising as a therapeutic approach that aims to design tailored dietary interventions to prevent and manage chronic diseases. Indeed, precision nutrition approaches contemplate the interindividual heterogeneity caused by genetic/epigenetic dissimilarities, individual facets such as age and gender, the lifestyle and environmental exposome diversity, microbiome variations, and singular behavioral/psychological features. On the other hand, the inclusion of potentially bioactive compounds and functional foods as promoters of healthy aging within personalised dietary patterns could be an effective strategy to delay the aging process and age-related chronic diseases. One of the main limitations of a dietary prescription is the lack of compliance, due to the complexity of the prescription itself and/or the lack of commitment of the individual. The inclusion of digital tools to empower and motivate individuals and to support them in the management of the dietary strategy could overcome this limitation. With this background, the general objective of this investigation is to design precision nutritional strategies based on the inclusion of functional foods and digital tools for preventing age-related chronic diseases in pre-senior and senior populations. Additionally, this study proposes alternative tools for cognitive assessments increasing the accessibility to cognitive assessment tools for this population as well as an innovative digital tool for cognitive stimulation which is personalized, monitored, and evidence-based.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2020
CompletedFirst Submitted
Initial submission to the registry
March 3, 2021
CompletedFirst Posted
Study publicly available on registry
March 8, 2021
CompletedMarch 8, 2021
March 1, 2021
2.2 years
March 3, 2021
March 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change From Baseline General Health Status at 3 Months
General health score encompassed twelve parameters, on a scale of 0 to 21, with higher scores indicating a worse overall health: * BMI * Waist Circumference * Glycosylated hemoglobin (HbA1C) * Total cholesterol * HDL-cholesterol * LDL-cholesterol * Triglycerides * Uric acid * Systolic Blood Pressure \| Diastolic Blood Pressure * Gastrointestinal Health (GSRT) * Cognitive Function * Extra negative point if reducing medication
0 months and 3 months
Secondary Outcomes (55)
Change From Baseline Weight at 3 Months
0 months and 3 months
Baseline height
0 months
Change From Baseline Body Mass Index at 3 Months
0 months and 3 months
Change From Baseline Fat Mass at 3 Months
0 months and 3 months
Change From Baseline Lean Mass at 3 Months
0 months and 3 months
- +50 more secondary outcomes
Study Arms (2)
Control diet
PLACEBO COMPARATORA conventional diet based on the current Spanish Mediterranean dietary guidelines: Spanish Society of Community Nutrition (SENC).
Nutriprecision diet
EXPERIMENTALA Mediterranean, balanced diet based on the inclusion of precision foods designed and developed within the framework of Nutriprecision project. A mobile application to empower and support the management of the dietary prescription. A digital tool for cognitive stimulation.
Interventions
Control diet: A Mediterranean conventional diet based on the current dietary guidelines of the Spanish Society of Community Nutrition (SENC). Participants were strongly advised to use the Healthy Eating Plate (Harvard) to structure and prepare the main meals (lunch and dinner). In this way, at least ½ of the plate should be composed of vegetables, ¼ of lean protein, and ¼ of low glycemic index carbohydrates. The diet encourages participants to eat 5 times/day (breakfast, lunch, dinner, and two snacks). Overall, the control diet was based on high consumption of vegetables and fruits, whole grains, healthy fats (olive oil), and healthy proteins (legumes, fish, and lean meat). There was not energy restriction in the control diet.
Nutriprecision diet: a Mediterranean balanced diet based on the inclusion of precision foods designed according to the particularities of the senior population. The selected precision foods were a) fruit compote, b) smoothie, c) extruded meat product, d) wholemeal bread, e) wholemeal biscuit and f) microwaveable deep-frozen vegetable products. The diet encourages participants to eat 5 times/day with a conventionally balanced distribution of macronutrients (50% of the total caloric value from carbohydrates, 20% from proteins, and 30% from lipids). There was not energy restriction, although the energy requirements of the participants were adjusted to a BMI of 25 kg/m2 to avoid an overestimate of calorie intake. A mobile application designed and developed to provide volunteers with information about follow-up visits, the assigned diet, recommendations, and messages to motivate them during the intervention. A digital tool for cognitive stimulation.
Eligibility Criteria
You may qualify if:
- Men and women aged 50-80 years
- BMI \>27 kg/m2
- One or more of the following risk factors:
- Glucose ≥100 to ≤125 mg/dL or type 2 diabetes (independently of antidiabetic medication)
- Hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg or under antihypertensive medication)
- LDL-cholesterol ≥160 mg/dL independently of lipid-lowering therapy
- HDL-cholesterol ≤40 mg/dL (men)/≤50 mg/dL (women), independently of lipid-lowering therapy
- Triglycerides ≥160 mg/dL independently of lipid-lowering therapy
- Waist Circumference ˃95 cm (men)/\>82 cm (women), independently of lipid-lowering therapy
- Sedentary behavior (AHA)\*
You may not qualify if:
- Relevant functional or structural digestive abnormalities (malformations, angiodysplasia, active peptic ulcers, chronic inflammatory diseases, or malabsorption)
- Endocrine disorders (hyperthyroidism or uncontrolled hypothyroidism)
- Undergone surgical interventions with permanent sequelae (gastroduodenostomy)
- Pharmacological treatments with immunosuppressants, cytotoxic agents, systemic corticosteroids, or other drugs that could potentially cause hepatic steatosis or alteration of liver tests
- Active cancer in the last five years or under therapy
- Weight loss ≥3 kg in the last three months
- Instable drug therapy in the last three months
- Severe psychiatric disorders
- No autonomy
- Inability to follow the diet (food allergies, intolerances)
- Difficulties to follow scheduled visits
- AHA Recommendations for Physical Activity in Adults: at least 150 minutes per week of moderate-intensity aerobic activity or 75 minutes per week of vigorous aerobic activity, or a combination of both, preferably spread throughout the week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Nutrition Research, University of Navarra
Pamplona, Navarre, 31008, Spain
Related Publications (3)
de Toro-Martin J, Arsenault BJ, Despres JP, Vohl MC. Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome. Nutrients. 2017 Aug 22;9(8):913. doi: 10.3390/nu9080913.
PMID: 28829397BACKGROUNDGonzalez-Muniesa P, Martinez JA. Precision Nutrition and Metabolic Syndrome Management. Nutrients. 2019 Oct 9;11(10):2411. doi: 10.3390/nu11102411.
PMID: 31601025BACKGROUNDBrooke, JB (1996). SUS - a quick and dirty usability scale. In: Usability Evaluation in Industry, Jordan, P, Thomas, B, Weerdmeester, B, and McLelland, I(eds), Taylor and Francis: London
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Itziar Abete Goñi, PhD
Centre for Nutrition Research - University of Navarra
- PRINCIPAL INVESTIGATOR
Santiago Navas Carretero, PhD
Centre for Nutrition Research - University of Navarra
- STUDY DIRECTOR
M Ángeles Zulet Alzórriz, Professor
Centre for Nutrition Research - University of Navarra
- STUDY DIRECTOR
Carlos Javier González Navarro, PhD
Centre for Nutrition Research - University of Navarra
- STUDY DIRECTOR
J. Alfredo Martínez Hernández, Professor
Centre for Nutrition Research - University of Navarra
- PRINCIPAL INVESTIGATOR
Viviana Loria Kohen, PhD
IMDEA Food
- STUDY CHAIR
Ana Ramirez Molina, PhD
IMDEA Food
- STUDY CHAIR
Guillermo Reglero Rada, Professor
IMDEA Food
- STUDY CHAIR
Elena Aguilar Aguilar, PhD
IMDEA Food
- STUDY CHAIR
Helena Marcos Pasero
IMDEA Food
- STUDY CHAIR
Susana Molina
IMDEA Food
- STUDY CHAIR
Carmen Crespo
IMDEA Food
- STUDY CHAIR
Cristina Galarregui Miquelarena
Centre for Nutrition Research - University of Navarra
- STUDY CHAIR
Blanca Martínez de Morentín, MD
Centre for Nutrition Research - University of Navarra
- STUDY CHAIR
Salomé Pérez Díez
Centre for Nutrition Research - University of Navarra
- STUDY CHAIR
María Hernández Ruiz de Eguilaz
Centre for Nutrition Research - University of Navarra
- STUDY CHAIR
Veronica Ciaurriz Fernández
Centre for Nutrition Research - University of Navarra
- STUDY CHAIR
María Zabala Navó
Centre for Nutrition Research - University of Navarra
- STUDY CHAIR
Begoña de Cuevillas García
Centre for Nutrition Research - University of Navarra
- STUDY CHAIR
José Manuel Iniesta Chamorro
Universidad Politécnica de Madrid (UPM)
- STUDY CHAIR
Paloma Chausa Fernández
Universidad Politécnica de Madrid (UPM)
- STUDY CHAIR
José Tapia Galisteo
Universidad Politécnica de Madrid (UPM)
- STUDY CHAIR
Elena Hernando Pérez
Universidad Politécnica de Madrid (UPM)
- STUDY CHAIR
Enrique J. Gómez Aguilera
Universidad Politécnica de Madrid (UPM)
- STUDY CHAIR
Alexis Álvarez Rollán
Grupo I.C.A. Informática y Comunicaciones Avanzadas, S.L.
- STUDY CHAIR
Alejandro García Rudolph
Institut Guttmann, University Institute attached to the Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain; Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès, Spain; The Health Sciences Research Institute of the Germans
- STUDY CHAIR
Alberto García Molina
Institut Guttmann, University Institute attached to the Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain; Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès, Spain; The Health Sciences Research Institute of the Germans
- STUDY CHAIR
Josep Maria Tormos Muñoz
Institut Guttmann, University Institute attached to the Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain; Universitat Autònoma de Barcelona, Bellaterra, Cerdanyola del Vallès, Spain; The Health Sciences Research Institute of the Germans
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 3, 2021
First Posted
March 8, 2021
Study Start
October 16, 2018
Primary Completion
December 23, 2020
Study Completion
December 23, 2020
Last Updated
March 8, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share